சுருக்கம்

The effect of daily administration of 300 mg of ovomet® for treatment of arthritis in elderly patients

Jorge Martinez-Iniguez Blasco, Andres Aguirre, Erena Gil-Quintana & Marisa Fenaux

Aim: To evaluate effectiveness of daily intake of 300 mg Ovomet® (egg membrane) for treatment of osteoarthritis elderly patients. Methods: This prospective study consisted of 300 mg Ovomet® intake for 50 days in 20 osteoarthritis patients previously diagnosed by medical examination. We collected demographic data, joint stiffness and function measurement (medical check-ups) and intensity of pain data (Western Ontario and McMaster Universities Osteoarthritis Index, WOMAC questionnaire) at baseline, day 10, 20, 30, 40 and 50 of Ovomet® intake. The pain rate at beginning of the study (13.4/20) was classified as “very acute”. There is a 35% significant improvement in overall joint at the end of the study. Results: Patients were male (55%) and female (45%) with a mean age of 73.5 ± 1.35 years (mean ± standard error). The daily intake of 300 mg Ovomet® caused a gradual and statistically significant reduction in pain and stiffness intensity, and improved the functional capacity since the early days of the study. At the end of the treatment, most of the patients (70% and 95%) had an improvement in pain and functionality levels equal to or more than 20% respectively. It should be pointed out that improvement in stiffness reached almost 60% after 50 days of Ovomet® intake. Conclusion: The daily intake of 300 mg Ovomet® for osteoarthritic treatment has been effective since the beginning. Ovomet® is presented as a natural alternative for the management of pain and disability that arthrosis causes, making a huge difference in life quality of elderly people.